Insurers Lead Earnings Week as Banks and Brokers Diverge
A mixed earnings week saw insurers deliver the biggest upside, banks post steady growth, and brokerages split on investor reaction. Travelers led the group with the largest EPS beat, while UnitedHealth and State Street showed that strong results do not always translate into higher shares.
Insurers delivered the strongest upside in the Oct. 13-16 earnings week, led by Travelers and UnitedHealth, while banks posted steady operating progress and brokerages produced a more uneven market response. The takeaway for investors is clear: earnings beats still matter, but guidance, execution risk, and business mix are driving stock reactions just as much as headline EPS results.
The week of Oct. 13 through Oct. 16 brought a clear earnings split: insurers delivered the strongest upside, banks posted steady progress, and brokerages produced a more mixed market response. Most of the focus stocks beat EPS estimates, but share-price reactions varied sharply, proving again that a strong quarter and a strong trading day are different things.
Key Takeaways
Travelers (TRV) posted the week's largest EPS beat among the focus stocks, with $9.18 versus a $7.39 estimate, while core income reached $1.95 billion.
UnitedHealth (UNH) beat its EPS estimate by $0.55, yet shares fell 1.29% in the quoted session as management worked through a broader operating reset.
Wells Fargo (WFC) paired 13% year-over-year EPS growth with 2% revenue growth and stronger returns across its operating businesses.
BlackRock (BLK) and State Street (STT) both beat EPS estimates, but BLK rose 1.21% while STT fell 1.12%, highlighting different investor readings of asset-management results.
UnitedHealth Group (UNH)
UnitedHealth reported third-quarter 2026 adjusted EPS of $4.69, ahead of the $4.14 estimate. The $0.55 beat was substantial, but the quoted share price fell $5.24, or 1.29%, to $401.43. Trading volume reached 8.1 million shares against a 5.1 million average, giving the move added weight.
The earnings call focused on execution across UnitedHealthcare and Optum. CEO Stephen Hemsley said actions taken during 2026 were driving progress and supported confidence in sustainable growth from 2027 onward within the company's 13% to 16% long-term target range. Management also revised full-year 2026 guidance, although the call excerpt did not include the revised figure.
Technology was a notable operating theme. AI-enabled chart summarization reached more than 40% of employed clinicians and reduced chart review time by 33%. AI-supported information gathering shortened appeal cycle times by 26%. UnitedHealth also plans to introduce AI-powered plan recommendations for the Medicare Advantage enrollment period.
The analyst consensus remains Buy, with 43 buys, 7 holds, and 2 sells. That constructive rating contrasts with the weak share reaction. The market appears to be placing more weight on execution risk and the pace of the turnaround than on the quarterly EPS beat alone.
Wells Fargo (WFC)
Wells Fargo delivered third-quarter EPS of $1.87, above the $1.85 estimate and up 13% from a year earlier. Revenue grew 2% year over year, with growth across all four operating segments. The quoted share price rose $1.12, or 1.35%, to $83.87.
The revenue mix was broad. Wealth and Investment Management revenue rose 12%, Commercial Banking gained 6%, Consumer Banking and Lending increased 5%, and Corporate and Investment Banking grew 3%. Lower venture-capital investment revenue and reduced lease income after the rail-car leasing sale partly offset those gains.
Returns also improved. Return on tangible common equity reached 16.3% for the quarter, compared with 14.7% during the first nine months of 2025. Expenses declined modestly from a year earlier, supporting the higher earnings result.
Capital-markets activity supplied extra momentum. M&A revenue increased 30%, while equity-capital-markets and investment-grade underwriting fees each rose 33%. Equities revenue climbed 21%. However, a slowdown during the final several weeks of the quarter hurt the Markets business, showing that the recovery still has uneven patches.
Analyst opinion is constructive but divided: 28 buys, 28 holds, and 4 sells produce a Buy consensus. The price gain fits the quarter's broad growth profile, although the balanced analyst split leaves room for debate over how much of the improvement is durable.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
BlackRock reported third-quarter adjusted EPS of $15.93, beating the $14.32 estimate by $1.61. Shares rose $13.60, or 1.21%, to $1,134.38 in the quoted session. Volume of 1.14 million shares was above the 607,000 average.
Management described a shift in client priorities. A year earlier, clients focused on inflation, interest rates, and growth uncertainty. In the latest quarter, the focus moved toward technology, artificial intelligence, infrastructure investment, and income strategies. Capital is flowing into infrastructure tied to AI and digital transformation, while wealth portfolios are expanding beyond traditional allocations.
That positioning gives BlackRock a broad growth angle rather than a single-product story. The firm can participate through institutional mandates, retail products, retirement solutions, and alternatives as clients seek wider diversification. The analyst consensus is Buy, with 26 buys, 7 holds, and no sell ratings. The positive share reaction matched both the EPS beat and the call's expansion-focused message.
State Street (STT)
State Street posted third-quarter EPS of $3.69, narrowly above the $3.68 estimate. Shares fell $1.88, or 1.12%, to $165.72 in the quoted session. The modest EPS beat did not translate into a gain, making STT one of the week's clearest examples of muted market enthusiasm.
CEO Ron O'Hanley framed the business around a complex investment landscape that includes sovereign debt pressure, credit risk, geopolitical uncertainty, inflation, AI, and cyber threats. His strategic answer is the One State Street model, which combines asset servicing, investment management, and markets capabilities.
The analyst view remains positive overall, with 18 buys, 15 holds, and 4 sells creating a Buy consensus. Still, the close split shows less conviction than BlackRock's analyst profile. State Street's quarter produced a beat, but the market demanded more than a narrow improvement against estimates.
Marsh & McLennan Companies (MRSH)
Marsh & McLennan reported third-quarter EPS of $2.03, above the $1.97 estimate. Shares gained $1.81, or 0.97%, to $188.35 in the quoted session. The market response was positive, though more measured than the reaction to Travelers.
Management described the current business environment as structural rather than cyclical. Wars, economic shifts, extreme weather, and advances in AI are changing client needs across risk, strategy, people, and investments. Marsh also announced the competitive resilience coalition with Bloomberg, which will bring business and government leaders together around resilience.
The company views AI as a positive force for its business and clients. That outlook supports demand for advice as companies adjust operating models and manage new risks. However, the analyst consensus is Hold, with 1 strong buy, 10 buys, 22 holds, and 1 sell. The result improved near-term sentiment, but the rating profile still reflects a measured view of valuation and growth.
Interactive Brokers Group (IBKR)
Interactive Brokers reported third-quarter EPS of $0.67, slightly above the $0.668 estimate. Yet shares dropped $3.34, or 3.88%, to $82.69 in the quoted session. The negative move was the sharpest among the focus stocks despite the earnings beat.
The operating figures were stronger than the headline EPS gap suggests. Pretax profit reached a record, and the pretax margin was 78%, marking the eighth straight quarter above 70%. Account growth exceeded 30%, with expansion among both institutional and individual investors across regions.
The call also highlighted market concentration. The S&P 500 rose 2% during the quarter, while the 10 largest U.S. technology stocks represented nearly 40% of the index's total value. Those technology names remained among the most actively traded stocks on the platform.
The analyst consensus is Buy, split between 9 buys, 9 holds, and 1 sell. That balance helps explain the sharper price sensitivity. A high-margin business with more than 30% account growth still faced a demanding market reaction when the EPS beat was only incremental.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Travelers produced the week's most powerful insurance result. Third-quarter core EPS reached $9.18, well above the $7.39 estimate. Core income totaled $1.95 billion, core return on equity reached 22.1%, and trailing four-quarter core return on equity stood at 24.1%.
Underwriting income reached $1.4 billion before tax. Management attributed the result to strong underlying underwriting income and favorable prior-year reserve development. Underwriting performance was strong across all three segments, and the investment portfolio produced a record result.
Shares climbed $5.65, or 1.47%, to $389.54 in the quoted session, bringing the stock close to its $398.70 yearly high. The move fit the quality of the quarter better than the modest gains at Marsh or the declines at UnitedHealth and State Street.
Analyst opinion remains cautious despite the strong print. The consensus is Hold, with 1 strong buy, 10 buys, 29 holds, and 4 sells. That disconnect is important: Travelers delivered excellent current results, while analysts still appear disciplined about treating one strong quarter as a complete change in the long-term outlook.
Wrap-Up
The past week's earnings recap shows broad operational strength, but not a uniform trading response. Travelers led on earnings quality, Wells Fargo showed balanced bank growth, and BlackRock offered the clearest asset-management upside, while UnitedHealth, State Street, and Interactive Brokers faced tougher market judgment despite beating EPS estimates.
For investors, the central lesson is simple: the size and quality of the beat matter, but so do guidance, business momentum, and the expectations already embedded in the stock price.
▌Common Questions
Frequently asked questions
+Which insurers led earnings this week?
Travelers and UnitedHealth were the standout insurers in the Oct. 13-16 earnings window. Travelers posted the largest EPS beat among the focus stocks, while UnitedHealth also beat estimates despite a negative share reaction.
+Why did UnitedHealth stock fall after beating earnings?
UnitedHealth beat EPS estimates by a wide margin, but investors focused more on the company's operating reset and execution risk than on the quarterly beat. The market appeared to want clearer evidence that the turnaround can support sustainable growth.
+Did Wells Fargo's earnings show real improvement?
Yes, Wells Fargo showed broad improvement with 13% year-over-year EPS growth, 2% revenue growth, and stronger returns across its businesses. Capital-markets activity also helped, although some late-quarter weakness showed the recovery is still uneven.
+Why did BlackRock rise while State Street fell after earnings?
Both firms beat EPS estimates, but investors responded more positively to BlackRock's growth narrative tied to AI, infrastructure, and income strategies. State Street's modest beat was not enough to offset a weaker market reaction to its results and outlook.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
